Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Telecommunications Network Measurements of Online Gambling Behavior in Switzerland: A Feasibility Study.

Bitar R, Nordt C, Grosshans M, Herdener M, Seifritz E, Mutschler J.

Eur Addict Res. 2017;23(2):106-112. doi: 10.1159/000471482. Epub 2017 Apr 13.

2.

Association of plasma calcium concentrations with alcohol craving: New data on potential pathways.

Schuster R, Koopmann A, Grosshans M, Reinhard I, Spanagel R, Kiefer F.

Eur Neuropsychopharmacol. 2017 Jan;27(1):42-47. doi: 10.1016/j.euroneuro.2016.11.007. Epub 2016 Nov 25.

PMID:
27890540
3.

Pregabalin Use Among Opioid-Addicted Patients in Switzerland.

Mutschler J, Gastberger S, Baumgartner MR, Grosshans M, Seifritz E, Quednow BB, Herdener M.

J Clin Psychiatry. 2016 Sep;77(9):1202-1203. doi: 10.4088/JCP.15l10296. No abstract available.

4.

The association of pineal gland volume and body mass in obese and normal weight individuals: a pilot study.

Grosshans M, Vollmert C, Vollstaedt-Klein S, Nolte I, Schwarz E, Wagner X, Leweke M, Mutschler J, Kiefer F, Bumb JM.

Psychiatr Danub. 2016 Sep;28(3):220-224.

5.

["Food addiction" as a possible risk factor for obesity].

Frey L, Riva M, Grosshans M, Mutschler J.

Praxis (Bern 1994). 2016 Mar 30;105(7):397-404. doi: 10.1024/1661-8157/a002309. Review. German.

PMID:
27005734
6.

Current Findings and Mechanisms of Action of Disulfiram in the Treatment of Alcohol Dependence.

Mutschler J, Grosshans M, Soyka M, Rösner S.

Pharmacopsychiatry. 2016 Jul;49(4):137-41. doi: 10.1055/s-0042-103592. Epub 2016 Mar 17. Review.

PMID:
26987743
7.

Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience.

Grosshans M, Mutschler J, Kiefer F.

Int Clin Psychopharmacol. 2015 Jul;30(4):237-8. doi: 10.1097/YIC.0000000000000069.

PMID:
25647453
8.

Oleoylethanolamide and human neural responses to food stimuli in obesity.

Grosshans M, Schwarz E, Bumb JM, Schaefer C, Rohleder C, Vollmert C, Vollstädt-Klein S, Tost H, Meyer-Lindenberg A, Kiefer F, Leweke FM.

JAMA Psychiatry. 2014 Nov;71(11):1254-61. doi: 10.1001/jamapsychiatry.2014.1215. Erratum in: JAMA Psychiatry. 2014 Dec 1;71(12):1408.

PMID:
25229205
9.

[Substance abuse in older adults].

Bitar R, Dürsteler KM, Rösner S, Grosshans M, Herdener M, Mutschler J.

Praxis (Bern 1994). 2014 Sep 3;103(18):1071-9. doi: 10.1024/1661-8157/a001777. Review. German.

PMID:
25183616
10.

Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.

Grosshans M, Mutschler J, Luderer M, Mann K, Kiefer F.

Clin Neuropharmacol. 2014 Jan-Feb;37(1):6-8. doi: 10.1097/WNF.0000000000000007.

11.

Treatment of severe sleep disorder related to alcohol-dependence with high-dose agomelatine - a case report.

Grosshans M, Mutschler J, Kiefer F.

Psychiatr Danub. 2013 Dec;25(4):416-8. No abstract available.

12.

Pregabalin abuse among opiate addicted patients.

Grosshans M, Lemenager T, Vollmert C, Kaemmerer N, Schreiner R, Mutschler J, Wagner X, Kiefer F, Hermann D.

Eur J Clin Pharmacol. 2013 Dec;69(12):2021-5. doi: 10.1007/s00228-013-1578-5. Epub 2013 Aug 30.

PMID:
23989299
13.

Hunger modulates behavioral disinhibition and attention allocation to food-associated cues in normal-weight controls.

Loeber S, Grosshans M, Herpertz S, Kiefer F, Herpertz SC.

Appetite. 2013 Dec;71:32-9. doi: 10.1016/j.appet.2013.07.008. Epub 2013 Jul 27.

PMID:
23899903
14.

Insula-specific H magnetic resonance spectroscopy reactions in heavy smokers under acute nicotine withdrawal and after oral nicotine substitution.

Gutzeit A, Froehlich JM, Hergan K, Graf N, Binkert CA, Meier D, Brügger M, Reischauer C, Sutter R, Herdener M, Schubert T, Kos S, Grosshans M, Straka M, Mutschler J.

Eur Addict Res. 2013;19(4):184-93. doi: 10.1159/000345915. Epub 2012 Dec 15.

15.

Functional polymorphism of the dopamine β-hydroxylase gene is associated with increased risk of disulfiram-induced adverse effects in alcohol-dependent patients.

Mutschler J, Abbruzzese E, Witt SH, Dirican G, Nieratschker V, Frank J, Grosshans M, Rietschel M, Kiefer F.

J Clin Psychopharmacol. 2012 Aug;32(4):578-80. doi: 10.1097/JCP.0b013e31825ddbe6. No abstract available.

PMID:
22760354
16.

Application of electronic diaries in patients with schizophrenia and bipolar disorders.

Mutschler J, von Zitzewitz F, Rössler W, Grosshans M.

Psychiatr Danub. 2012 Jun;24(2):206-10.

17.

[Pregabalin for the reduction of opiate withdrawal symptoms].

Kämmerer N, Lemenager T, Grosshans M, Kiefer F, Hermann D.

Psychiatr Prax. 2012 Oct;39(7):351-2. doi: 10.1055/s-0032-1305042. Epub 2012 Jun 11. German.

PMID:
22689280
18.

Functional social support within a medical supervised outpatient treatment program.

Mutschler J, Eifler S, Dirican G, Grosshans M, Kiefer F, Rössler W, Diehl A.

Am J Drug Alcohol Abuse. 2013 Jan;39(1):44-9. doi: 10.3109/00952990.2012.677889. Epub 2012 May 17.

PMID:
22594669
19.

Association of leptin with food cue-induced activation in human reward pathways.

Grosshans M, Vollmert C, Vollstädt-Klein S, Tost H, Leber S, Bach P, Bühler M, von der Goltz C, Mutschler J, Loeber S, Hermann D, Wiedemann K, Meyer-Lindenberg A, Kiefer F.

Arch Gen Psychiatry. 2012 May;69(5):529-37. doi: 10.1001/archgenpsychiatry.2011.1586.

PMID:
22566584
20.

Epigenetic alteration of the dopamine transporter gene in alcohol-dependent patients is associated with age.

Nieratschker V, Grosshans M, Frank J, Strohmaier J, von der Goltz C, El-Maarri O, Witt SH, Cichon S, Nöthen MM, Kiefer F, Rietschel M.

Addict Biol. 2014 Mar;19(2):305-11. doi: 10.1111/j.1369-1600.2012.00459.x. Epub 2012 Apr 16.

PMID:
22506971

Supplemental Content

Loading ...
Support Center